Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301.
Sakata S, Saeki S, Okamoto I, Otsubo K, Komiya K, Morinaga R, Yoneshima Y, Koga Y, Enokizu A, Kishi H, Hirosako S, Yamaguchi E, Aragane N, Fujii S, Harada T, Iwama E, Semba H, Nakanishi Y, Kohrogi H. Sakata S, et al. Among authors: kishi h. Lung Cancer. 2016 Sep;99:41-5. doi: 10.1016/j.lungcan.2016.06.009. Epub 2016 Jun 14. Lung Cancer. 2016. PMID: 27565912 Clinical Trial.
Dose escalation and pharmacokinetic study of carboplatin plus pemetrexed for elderly patients with advanced nonsquamous non-small-cell lung cancer: Kumamoto thoracic oncology study group trial 1002.
Sakata S, Sasaki J, Saeki S, Hamada A, Kishi H, Nakamura K, Tanaka H, Notsute D, Sato R, Saruwatari K, Iriki T, Akaike K, Fujii S, Hirosako S, Kohrogi H. Sakata S, et al. Among authors: kishi h. Oncology. 2015;88(4):201-7. doi: 10.1159/000369255. Epub 2014 Dec 6. Oncology. 2015. PMID: 25502447
Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters.
Endo-Tsukude C, Sasaki JI, Saeki S, Iwamoto N, Inaba M, Ushijima S, Kishi H, Fujii S, Semba H, Kashiwabara K, Tsubata Y, Hayashi M, Kai Y, Saito H, Isobe T, Kohrogi H, Hamada A. Endo-Tsukude C, et al. Among authors: kishi h. Biol Pharm Bull. 2018;41(1):47-56. doi: 10.1248/bpb.b17-00521. Biol Pharm Bull. 2018. PMID: 29311482 Free article.
Expression of constitutively activated EGFRvIII in non-small cell lung cancer.
Okamoto I, Kenyon LC, Emlet DR, Mori T, Sasaki J, Hirosako S, Ichikawa Y, Kishi H, Godwin AK, Yoshioka M, Suga M, Matsumoto M, Wong AJ. Okamoto I, et al. Among authors: kishi h. Cancer Sci. 2003 Jan;94(1):50-6. doi: 10.1111/j.1349-7006.2003.tb01351.x. Cancer Sci. 2003. PMID: 12708474 Free PMC article.
Pneumothorax in a Patient with Unilateral Pulmonary Artery Agenesis.
Anai M, Sakata S, Kishi H, Yatsunami K. Anai M, et al. Among authors: kishi h. Intern Med. 2018 Jan 1;57(1):145-147. doi: 10.2169/internalmedicine.9093-17. Epub 2017 Oct 16. Intern Med. 2018. PMID: 29033433 Free PMC article. No abstract available.
Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia.
Anai M, Akaike K, Iwagoe H, Akasaka T, Higuchi T, Miyazaki A, Naito D, Tajima Y, Takahashi H, Komatsu T, Masunaga A, Kishi H, Fujii K, Fukuda K, Tomita Y, Saeki S, Ichiyasu H, Sakagami T. Anai M, et al. Among authors: kishi h. Respir Investig. 2021 Mar;59(2):187-193. doi: 10.1016/j.resinv.2020.10.009. Epub 2020 Nov 23. Respir Investig. 2021. PMID: 33281114 Free PMC article.
601 results